arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

Lifevantage Corp

LFVN
$6.16 ▼ -0.08 (-1.28%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
17 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
68
Health
Good
Neutral
auto_awesome

Analytical Summary

Lifevantage Corp shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $77.2M
Dividend Yield 3.00%
Revenue Growth -20.1%
Op. Margin 3.3%
ROIC 15.2%
FCF / Share $0.53
Trailing P/E 15.4x
Price / Book 2.3x
FCF Yield 8.6%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$182.59M
↓ -20.1%
Net Income Profit after all expenses
$5.07M
↓ -48.3%
Operating Margin Operating profit as % of sales
3.3%
↓ -37.4% 38th
FCF / Share Free cash flow per share
$0.53
↓ -38.0%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%

Health Breakdown

Profitability
37
Returns
71
Financial Health
98
Cash Quality
74

Dividend History

Dividend / share · sourced from SEC filings
$0.18 Latest / share
+12.1% YoY
+57.6% 5-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 65 quarters